UCSF Launches First Public Archive of Firearm Industry Records
UCSF is to become of the repository of a new class of industry documents due to a settlement in the state of Minnesota.
University of California San Francisco
For Early Prostate Cancer ‘Active Surveillance’ Is Now #1 Choice
The number of low and intermediate-risk prostate cancer patients undergoing active surveillance in place of aggressive treatment has tripled to quadrupled over the last 20 years.
Building a Culture of Well-Being: UCSF Earns Gold Recognition
UCSF is celebrating continued recognition for its commitment to supporting the health and well-being of its workforce.
Unexpected Findings Add New Insight on Cannabis and Heart Health
A new trial showed that inhaled cannabis was associated with a statistically significant 9% reduction in ectopic beats, which can sometimes signal a serious heart condition. While this finding wouldn't necessarily influence clinical decisions, it does indicate a need for further study and highlights the complex picture of the effects of cannabis on health.
How to Prepare Young Athletes for a Safe Return to School Sports
Orthopedic surgeon Dr. Nirav Pandya provides insight on how to ensure school-age children are prepared to play fall sports, including how to help them prevent early-season injuries.
Adults Living with HIV Are at High Risk for Diabetes. Here’s Why
UCSF reserachers discover why people with controlled HIV are at much higher risk for diabetes than HIV-negative people.
Chugai and UCSF to Collaborate on Drug Discovery Research
Chugai Pharmaceutical Co., Ltd. and UC San Francisco have entered into a Master Collaboration Agreement to advance drug discovery research. The multi-year agreement establishes a framework to facilitate research collaborations in areas including the exploration of disease biology, the identification of novel drug targets, and the development of new therapeutic approaches. An initial research project is already underway with a UCSF principal investigator.
Can Mini Organs Help Predict Breast Tumors’ Response to Therapy?
Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from an innovative clinical trial called I-SPY and rapid experimentation on lab-grown mini tumors.
The advance could hasten more personalized treatments for breast cancer, including the triple negative type, which is especially aggressive and hard to treat.
How the Deadly Superbug Infiltrating Hospitals Hides in Your Skin
Teams of researchers at UCSF discover how C. auris, a fungal superbug that can make a difficult hospitalization deadly, stows itself in hair follicles to evade the skin's typical immune defenses.